Endpoints for the assessment of response to gastroesophageal reflux disease therapy - What are the appropriate measures of " success"?

Reviews in Gastroenterological Disorders

Volumn 4, Issue 3, 2004, Pages 118-128

  Johnson, David A ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Endoscopy; Gastroesophageal reflux disease (GERD); GERD outcomes; GERD therapy; pH monitoring; Quality of life assessment

Indexed keywords

CISAPRIDE; ERYTHROMYCIN; ESOMEPRAZOLE; HISTAMINE H2 RECEPTOR AGONIST; LANSOPRAZOLE; METOCLOPRAMIDE; PLACEBO; PROTON PUMP INHIBITOR; STOMACH SECRETION INHIBITOR;

CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; ENDOSCOPY; ESOPHAGITIS; ESOPHAGUS MOTILITY; ESOPHAGUS PH; EVIDENCE BASED MEDICINE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; LOWER ESOPHAGUS SPHINCTER; MEDICAL ASSESSMENT; METHODOLOGY; PATIENT MONITORING; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ENDOSCOPY, GASTROINTESTINAL; ESOPHAGUS; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; OUTCOME ASSESSMENT (HEALTH CARE); PERISTALSIS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS;

EID: 4644313414     PISSN: 1533001X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Tuttle SG, Rufin F, Bettarello A. The physiology of heartburn. Ann Intern Med. 1961;55:292-300.
2. Weusten B, Smout AJPM. Ambulatory monitoring of esophageal pH and pressure. In: Castell DO, Richter J, eds. The Esophagus. Philadelphia: Lippincott Williams & Wilkins; 2004:135-164.
3. Kahrilas PJ, Quigley EM. Clinical esophageal pH monitoring: a technical review of practice guideline development. Gastroenterology. 1996; 110:1982-1986.
4. Pandolfino JE, Richer JE, Ours T, et al. Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol. 2003; 98:740-749.
5. Grande L, Pujol A, Ros E, et al. Intraesophageal pH monitoring after breakfast and lunch in gastroesophageal reflux disease. J Clin Gastroenterol. 1988;10:373-376.
6. Jorgensen F, Elsborg L, Hesse B. The diagnostic value of computerized short term esophageal pH monitoring in suspected gastroesophageal reflux. Scand J Gastroenterol. 1988;23:363-368.
7. Bianchi Porro G, Pace F. Comparison of three methods of intraesophageal pH recording in the diagnosis of gastroesophageal reflux. Scand J Gastroenterol. 1988;23:743-758.
8. Clark CS, Kraus BB, Sinclair J, et al. Gastroesophageal reflux induced by exercise in healthy volunteers. JAMA. 1989;261:3599-3601.
9. Johnsson F, Joelsson B. Reproducibility of ambulatory oesophageal pH monitoring. Gut. 1988;29:886-889.
10. Schindlbeck NE, Heinrich C, Konig A, et al. Optimal thresholds, sensitivity, and specificity of long-term pH-metry for the detection of gastroesophageal reflux disease. Gastroenterology. 1987;93:85-90.
11. Wang H, Beck IT, Paterson WG. Reproducibility and physiologic characteristics of 24-hour ambulatory esophageal manometry/pH-metry. Am J Gastroenterol. 1996;91:493-497.
12. Vandeplas Y, Helven R, Goyvaerts H, Sacre L. Reproducibility of continuous 24 hour oesophageal pH monitoring in infants and children. Gut. 1990;31:374-377.
13. Murphy DW, Yuan Y, Castell DO. Does the intraesophageal pH probe accurately detect acid reflux? Simultaneous recording with two pH probes in humans. Dig Dis Sci. 1989;34:649-656.
14. Lundell LR. Surgical treatment of gastroesophageal reflux disease. In: Castell DO, Richter JE, eds. The Esophagus. Philadelphia: Lippincottt Williams & Wilkins; 2004:564-571.
15. Spechler SJ, Lee E, Ahnen D, et al. Long term outcomes of medical and surgical therapies for gastroesophageal reflux disease. Follow-up of a randomized controlled trial. JAMA. 2001; 285;2331-2338.
16. Triadafilopoulos G. Clinical experience with the Stretta procedure. Gastrointest Endosc Clin N Am. 2003;13:147-155.
17. Corley DA, Katz P, Wo M, et al. Temperature controlled radiofrequency energy delivery to the gastroesophageal junction for the treatment of GERD (the Stretta procedure): a randomized, double-blind, sham controlled, multi-center clinical trial. Gastroenterology. 2003;125:668-676.
18. Rothstein RI, Filipi CJ. Endoscopic suturing for gastroesophageal reflux disease: clinical outcome with the Bard EndoCinch. Gastrointest Endosc Clin N Am. 2003; 13:89-101.
19. Fennerty MB. Endoscopic suturing for treatment of GERD. Gastrointest Endosc. 2003;57:390-395.
20. Kahrilas PJ. Radiofrequency therapy of the lower esophageal sphincter for treatment of GERD. Gastrointest Endosc. 2003;57:723-731.
21. Edmundowicz SA. Injection therapy of the lower esophageal sphincter for the treatment of GERD. Gastointest Endosc. 2004;59:545-552.
22. Pleskow D, Rothstein R, Lo S, et al. Endoscopic full thickness plication for the treatment of GERD: a multicenter study. Gastrointest Endosc. 2004;59:163-171.
23. Milkes D, Gerson LB, Triadafilopoulos G. Elimination of reflux symptoms does not guarantee normalization of intraesophageal and intragastric pH in patients with gastroesophageal reflux disease (GERD). Am J Gastroenterol. 2004;99:991-996.
24. Dent J, Holloway RH, Toouli J, et al. Mechanisms of lower esophageal sphincter incompetence in patients with symptomatic gastroesophageal reflux. Gut. 1988;29:1020-1024.
25. Mital RK, Holloway RH, Penagini R, et al. Transient lower esophageal sphincter relaxation. Gastroenterology. 1995;109:601-606.
26. DeMeester TR, Wernly JA, Brian GH, et al. Clinical and in vitro analysis of determinatnts of gastroesophageal competence: a study of principles of antireflux surgery. Am J Surg. 1979;137:39-44.
27. Johnsson F, Holloway RH, Ireland AC, et al. Effect of fundoplication on transient lower oesophageal sphincter relaxation and gas reflux. Br J Surg. 1997;84:686-689.
28. Utley DS, Kim MS, Vierra MA, Triadafilopoulos G. Augmentation of lower esophageal sphincter pressure and gastric yield pressure after radiofrequency energy delivery to the gastroesophageal sphincter junction: a porcine model. Gastrointest Endosc. 2000;52:81-86.
29. Mason RJ, Hughes M, Lehman GA, et al. Endoscopic augmentation of the cardia with a biocompatible injectable polymer (Enteryx) in a porcine model. Surg Endosc. 2002;16:386-391.
30. Tam WCE, Holloway RH, Dent J, et al. Impact of endoscopic suturing on lower esophageal sphincter function in GERD. Am J Gastroenterol. 2004;99:195-202.
31. Tam WC, Schoeman MN, Zhang Q, et al. Delivery of radiofrequency energy to the lower oesophageal sphincter and gastric cardia inhibits transient lower oesophageal sphincter relaxations and gastro-oesophageal reflux in patients with reflux disease. Gut. 2003;52:479-485.
32. Maton P. Efficacy and safety of GERD pharmacotherapy. In: Richter JE, ed. Healing Horizons in Acid Reflux Disease. Cleveland, OH: Cleveland Clinic Foundation; 2003:183-212.
33. Lauritsen K, Deviere J, Bigard MA, et al. Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis. Metropole study results. Aliment Pharmacol Ther. 2003;17:333-341.
34. Winters C, Spurling TJ, Chobanian SJ, et al. Barrett's esophagus: a prevalent complication of gastroesophageal reflux disease. Gastroenterology. 1987;92:118-124.
35. DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol. In press.
36. Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagtitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999; 45:172-180.
37. Johnson DA. GERD treatment protocol. In: Richter JE, ed. Healing Horizons in Acid Reflux Disease. Cleveland, OH: Cleveland Clinic; 2003: 247-274.
38. Luostarinen M. Nissen fundoplication for reflux esophagitis: long term clinical and endoscopic results in 109-127 consecutive patients. Ann Surg. 1993;217:329-337.
39. Campbell R, Kennedy T, Johnston GW. Gastric ulceraton after Nissen fundoplication. Br J Surg. 1983;70:406-407.
40. Triadafilopoulos G, DiBaise JK, Nostrant TT, et al. Radiofrequency energy delivery to the gastroesophageal junction for the treatment of gastroesophageal reflux disease. Gastrointest Endosc. 2001;53:407-415.
41. Triadafilopoulos G, DiBaise JK, Nostrant TT, et al. The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial. Gastointest Endosc. 2002;55:149-156.
42. Johnson DA, Ganz R, Aisenberg J, et al. Endoscopic implantation of Enteryx for GERD treatment: 12-month results of a prospective multi-center trial. Am J Gastroenterol. 2003; 98:1921-1926.
43. Liu JJ, Saltzman J, Ookubo R, Carr-Locke DL. Predictors of long-term success of endoscopic treatment for gastroesophageal reflux disease. Gastroenterology. 2004;126:A331.
44. Carlsson R, Dent J, Bolling-Sternevald E, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol. 1998; 33:1023-1029.
45. Bytzer P. Assessment of reflux symptom severity: methodological options and their attributes. Gut. 2004;53(suppl IV):iv28-iv34.
46. Guyatt G, Berman LB, Townsend M, et al. Should study subjects see their previous responses? J Chronic Dis. 1985;38:1003-1007.
47. Klaus A, Hinder RA, DeVault KR, Achem SR. Bowel dysfunction after laparoscopic antireflux surgery: incidence, severity, clinical course. Am J Med. 2003;114:6-9.
48. Dent J, Armstrong D, Delaney B, et al. Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut. 2004;53(suppl IV):iv1-iv24.
49. Filipi CJ, Lehman GA, Rothstein RI, et al. Transoral, flexible endoscopic suturing for treatment of GERD: a multi-center trial. Gastrointest Endosc. 2001;53:416-422.
50. Rothstein RI, Hynes ML, Grove MR, et al. Endoscopic gastric plication (EndoCinch) for GERD: a randomized, sham-controlled, blinded, single-center study. Gastrointest Endosc. 2004;59:AB111.
51. Revicki DA, Crawley JA, Zodet MW, et al. Complete resolution of heartburn symptoms and health related quality of life in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 1999;13:1621-1630.
52. Junghard O, Wiklund IK. A comparison of patient and clinician ratings of heartburn. Gastroenterology. 2003;124(4 suppl 1):A541.
53. McColl E. Best practice in symptom assessment: a review. Gut. 2004;53(suppl IV):iv49-iv54.
54. Irvine EJ. Quality of life assessment in gastro-oesophageal reflux disease. Gut. 2004;53(suppl IV):iv 35-iv39.
55. Fernando HC, Aschauer PR, Rosenblatt M, et al. Quality of life after anti-reflux surgery compared with non-operative management of severe gastro-esophageal reflux disease. J Am Coll Surg. 2002;194:23-27.
56. Velanovich V. Using quality-of-life measurements to predict patient satisfaction outcomes for antireflux surgery. Arch Surg. 2004; 139:621-625.
57. Holzman MD, Mitchel EF, Ray WA, Smalley WE. Use of healthcare resources among medically and surgically treated patients with gastroesophageal reflux disease: a population-based study. J Am Coll Surg. 2001;192:17-24.
58. Vakil N, Shaw M, Kirby R. Clinical effectiveness of laparoscopic findings in a U.S. community. Am J Med. 2003;114:1-5.
59. Pelletier EM, Sullivan E, Johnson DA. Use of sustained acid reduction therapy and medical costs among surgically managed GERD patients. Gastroenterology. 2003;124:A-18.